Bravelle approval (correction)
Executive Summary
Ferring's Bravelle (urofollitropin) is the fourth human-derived gonadotropin on the market, following Serono's Fertinex (urofollitropin) and Pergonal (menotropins), and Ferring's Repronex (menotropins). Bravelle and Fertinex are follitropins, while Pergonal and Repronex are not (1"The Pink Sheet" May 13, In Brief)...